Cerus Corp. Sets New 52-Week Low at $3.66 (CERS)
Cerus Corp. (NASDAQ:CERS) shares hit a new 52-week low during mid-day trading on Tuesday , Analyst Ratings Network reports. The company traded as low as $3.66 and last traded at $3.69, with a volume of 649,324 shares trading hands. The stock had previously closed at $3.95.
CERS has been the subject of a number of recent research reports. Analysts at Cantor Fitzgerald cut their price target on shares of Cerus Corp. from $8.00 to $7.00 in a research note on Monday, May 5th. They now have a “buy” rating on the stock. Analysts at MLV & Co
cut their price target on shares of Cerus Corp. from $8.50 to $6.00 in a research note on Friday, May 2nd. They now have a “buy” rating on the stock.
The stock’s 50-day moving average is $4.17 and its 200-day moving average is $5.35. The company’s market cap is $272.6 million.
Cerus Corp. (NASDAQ:CERS) last announced its earnings results on Thursday, May 1st. The company reported ($0.12) EPS for the quarter, meeting the Thomson Reuters consensus estimate of ($0.12). The company had revenue of $7.86 million for the quarter, compared to the consensus estimate of $9.65 million. The company’s quarterly revenue was down 19.2% on a year-over-year basis. On average, analysts predict that Cerus Corp. will post $-0.49 earnings per share for the current fiscal year.
Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.